Pablo G. Legorreta

CIK 1507678 · CEO, Chairman of the Board · last filed 2026-08-07

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$136.69M

Companies

3

Total Filings

26

Lifetime Open-Market Net

$19.59M

Filer Profile

Reported Address
110 E 59TH STREET
SUITE 3300
NEW YORK, NY 10022
Related Filers
RP Management, LLC — 7 joint filings, latest 2022-08-16
Tolerantia, LLC — 7 joint filings, latest 2025-06-05
Pharma Investments 2019 ICAV Royalty — 2 joint filings, latest 2022-08-16
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RPRX CEO, Chairman of the Board 1,426,320 $63.96 $91.23M $19.59M 19 2026-08-07
PROK Director 22,617,909 $2.01 $45.46M $0 5 2026-05-29
Epizyme, Inc. (EPZM) Delisted Director 9,166,667 $1.47 $13.48M $0 2 2020-06-02

Recent Filings · Page 2 of 3

26 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-05-09 RPRX Grant (A) +288,352 $0 EDGAR
2025-02-06 PROK Mixed $0 EDGAR
2024-06-03 PROK Grant (A) $0 EDGAR
2023-11-16 RPRX Mixed −90,809 $0 EDGAR
2023-07-03 PROK Grant (A) $0 EDGAR
2023-06-28 RPRX Buy (P) +130,000 $3.84M EDGAR
2023-06-13 RPRX Buy (P) +90,000 $2.96M EDGAR
2023-05-24 RPRX Buy (P) +150,000 $4.84M EDGAR
2023-05-17 RPRX Buy (P) +230,000 $7.68M EDGAR
2023-05-15 RPRX Gift (G) $0 EDGAR
Showing 1120 of 26
Page 2 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.